Share Twitter LinkedIn Facebook Email Nataliya Mar, MD, UC Irvine Health, talks about Phase 1 Urothelial Carcinoma Data Presented | Combination Therapies in Renal Cell Carcinoma at MOASC 2018
Tivozanib for RCC: Unpacking Efficacy, Safety, and Dose Optimization – Bradley McGregor, MD – Dana Farber Genitourinary 3 Mins Read
Renal Cell Carcinoma TiNivo-2 Study: Patient-Reported Outcomes in Treatment Post-ICI Kidney 3 Mins Read
VIDEO: FDA Approves Atezolizumab / Tecentriq Hybreza For Subcutaneous PD-(L)1 Cancer Immunotherapy in NSCLC Kidney 4 Mins Read